Abstract
Degradable starch microspheres (DSM) mixed and injected with a cytostatic drug might improve intra-arterial chemotherapy by increasing the local drug concentration.
Several factors are of importance for an optimal effect of the microspheres, e.g. size and vascularity of the tumour, arterial blood flow and arterio-venous shunts. Therefore, the dose of DSM has to be individualized. A method for continuous monitoring of the effect of DSM was developed. A radiolabelled marker was injected intra-arterially mixed with DSM and mitomycin C. Two kinetic parameters—Passing Fraction and Marker Flow Rate—were found to be influenced by the microspheres and thus seemed to be useful for monitoring the DSM-treatment.
Arterio-venous shunting was measured as passage of99Tcm-labelled macroaggregated albumin through the liver to the lungs. Significant increase of shunting after injection of DSM was demonstrated in 15 out of 19 patients.
Almost no effect of the microspheres was seen in patients with marked arterio-venous shunting or minimal reduction of the marker flow rate, but in others the passage of the labelled marker could generally be significantly reduced.
Similar content being viewed by others
References
Aronsen K F, Hellekant C, Holmberg J, Rothman U, Teder H: Controlled blocking of hepatic artery flow with enzymatically degradable microspheres combined with oncolytic drugs.Eur Surg Res 11, 99 (1979).
Dakhil S, Ensminger W, Cho K, Niederhuber J, Doan K, Wheeler R: Improved regional selectivity of hepatic arterial BCNU with degradable microspheres.Cancer 50, 631 (1982).
Ensminger W D, Gyves J W, Stetson P, Walker-Andrews S: Phase I study of hepatic arterial degradable starch microspheres and Mitomycin.Cancer Res 45, 4464 (1985).
Gyves J W, Ensminger W D, Van Harken D, Niederhuber J, Stetson P, Walker S: Improved regional selectivity of hepatic arterial Mitomycin by starch microspheres.Clin Pharmac Ther 34, 259 (1983).
Lindberg B, Lote K, Teder H: Biodegradable starch microspheres—A new medical tool. In Davis S S, Illum L, McVie J G, Tomlinson E (eds):Microspheres and Drug Therapy, p. 153. Amsterdam, Elsevier (1984).
Lindell B, Aronsen K F, Nosslin B, Rothman U: Studies in pharmacokinetics and tolerance of substances temporarily retained in the liver by microsphere embolization.Ann Surg 187, 95 (1978).
Lorelius L E, Benedetto A R, Blumhardt R, Gaskill H V, Lancaster J L, Stridbeck H: Enhanced drug retention in VX2 tumors by use of degradable starch microspheres.Invest Radiol 19, 212 (1984).
Teder H, Aronsen K F, Lindell B, Rothman U: Studies in pharmacokinetics of 5-fluoro-uracil temporarily retained in the rat liver by degradable starch microsphere embolization.Acta Chir Scand 144 (suppl 487), 71 (1978).
Teder H, Christensson PI, Aronsen K F, Lewan L, Ljungberg J, Stenram U: Hepatic artery administration of degradable starch microspheres. I. Effect on energy charge and incorporation of precursors into rat liver nucleic acids.Res Exp Med 185, 405 (1985).
Tuma R F, Forsberg J O, Ågerup B: Enhanced uptake of Actinomycin D in the dog kidney by simultaneous injection of degradable starch microspheres into the renal artery.Cancer 50, 1 (1982).
Starkhammar H, Håkansson L, Morales O, Svedberg J: Intra-arterial Mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres.Acta Oncol 26, in press (1987).
Starkhammar H, Håkansson L, Leander E, Svedberg J: A recording system for passage of radiolabelled substances into the systemic circulation. A methodological study on the effect of intra-arterially injected starch microspheres. Submitted for publication.
Starkhammar H, Håkansson L, Sjödahl R, Svedberg J, Ekberg S: Effect of portal blood flow and intraarterial injected starch microspheres on the passage of a radiolabelled tracer through the liver. An experimental study in pigs.Acta Oncol 26, in press (1987).
Bledin A G, Kim E E, Harle T S, Haynie T P, Chuang V P: Technetium-99m-labeled macroaggregated albumin arteriography for detection of abnormally positioned arterial catheters during infusion chemotherapy.Cancer 53, 858 (1984).
Kaplan W D, Come S E, Takvorian R W, Laffin S M, Gelman R S, Weiss G R, Garnick M B: Pulmonary uptake of Technetium 99m macroaggregated albumin: A predictor of gastrointestinal toxicity during hepatic artery perfusion.J Clin Oncol 2, 1266 (1984).
Kim E E, Legaspi J R, Haynie T P, Wallace S: Transcatheter infusion of99Tcm MAA for predicting response of intra-arterial chemotherapy in osteogenic sarcoma.Eur J Clin Oncol 21, 35 (1985).
Zeissman H A, Thrall J W, Gyves J W, Ensminger W D, Niederhuber J E, Tuscan M, Walker S: Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy.J Nucl Med 24, 871 (1983).
Rhodes B A, Rutherford R B, Lopez-Majano V, Greyson N D, Wagner H N Jr: Arteriovenous shunt measurements in extremities.J Nucl Med 13, 357 (1972).
McCuskey R S: A dynamic and static study of hepatic arterioles and hepatic sphincters.Am J Anat 119, 455 (1965).
Elias H, Petty D: Terminal distribution of the hepatic artery.Anat Rec 116, 116 (1953).
Geumei A M: Intrahepatic vascular pathways in the isolated perfused normal human liver with special reference to arterioportal shunt.Surgery 66, 319 (1969).
Mitra S K: The terminal distribution of the hepatic artery with special reference to arterio-portal anastomosis.J Anat 100, 651 (1966).
Sherman J L: Normal arteriovenous anastomoses.Medicine 42, 247 (1963).
Rappaport A M: The microcirculatory hepatic unit.Microvasc Res 6, 212 (1973).
Wakim K G, Mann F C: The intrahepatic circulation of blood.Anat Rec 82, 233 (1942).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Starkhammar, H., Håkansson, L., Morales, O. et al. Effect of microspheres in intra-arterial chemotherapy. A study of arterio-venous shunting and passage of a labelled marker. Med. Oncol. & Tumor Pharmacother. 4, 87–96 (1987). https://doi.org/10.1007/BF02934945
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02934945